Skip to content
DraconiticResearch
Search Sources API
182,460 studies31 sourcesUpdated 23 min ago
Peer-reviewedCC BY-NC-NDTaiwan Journal of Ophthalmology

Combined central retinal and posterior ciliary artery occlusion in a young female with primary myelofibrosis and Sweet’s syndrome: A case report

Abstract

Primary myelofibrosis (PMF) is a rare myeloproliferative neoplasm that typically affects older adults but may present aggressively in younger patients. Thromboembolic complications are well recognized, though arterial occlusions are uncommon in this age group. Ocular ischemia associated with systemic inflammatory conditions such as Sweet’s syndrome is exceedingly rare. A 22-year-old female with PMF, diagnosed 18 months earlier and managed initially with ruxolitinib, presented with sudden, complete loss of vision in her left eye. She also had a history of Sweet’s syndrome managed with oral corticosteroids and had received multiple blood transfusions. Ophthalmic evaluation revealed no light perception in the left eye, a pale retina with attenuated vessels, and a cherry-red spot. Optical coherence tomography (OCT) showed hyperreflectivity of the inner retinal layers, and OCT angiography demonstrated markedly reduced perfusion in all vascular plexuses. Carotid Doppler, echocardiography, and ECG excluded embolic sources. Despite ocular massage, anterior chamber paracentesis, acetazolamide, and anticoagulation with apixaban, vision did not recover. One week later, she developed anterior uveitis, keratic precipitates, and elevated intraocular pressure. Fundus showed Amalric’s sign of choroidal infarction and Elschnig spots, confirmed on fluorescein angiography. Inflammation responded to topical and systemic corticosteroids, with normalization of intraocular pressure. This is the first documented case of combined central retinal artery occlusion and posterior ciliary artery occlusion with anterior uveitis in a young PMF patient with Sweet’s syndrome. The case underscores the multifactorial contribution of hypercoagulability, systemic inflammation, and transfusion-related factors in ocular ischemia.

Related

  1. Delayed-onset central neurotoxic syndrome with predominant cerebellar dysfunction following combined chlorpyrifos and cypermethrin poisoning: a case report
    Sobin Pant, Dibij Adhikari, Anush Acharya +3
    Annals of medicine and surgery (2012)Peer-reviewedCC BY-NCFull textGeneral medicineEurope PMC
  2. Extramedullary Hematopoiesis Showing Lymphadenopathy in Myelodysplastic Syndrome without Myelofibrosis
    Satoshi Ichikawa, Fumiyoshi Fujishima, Tomonori Ishii
    Internal MedicinePeer-reviewedCC BY-NC-NDFull textGeneral medicineJ-STAGE
  3. Endovascular Recanalization of Non-Acute Vertebrobasilar Occlusion in Progressive Posterior Circulation Ischemia: A Case Report
    Gamaliel Wibowo Soetanto, Elvan Wiyarta
    Neurology internationalPeer-reviewedCC BYFull textGeneral medicineEurope PMC
  4. Predictive value of a combined model based on immune indicators and clinical characteristics for the prognosis of patients with primary myelofibrosis
    TIAN Juan, XUE Yimiao, WEI Yuping +2
    Zhongguo linchuang yanjiuPeer-reviewedCC BY-NC-NDFull textHuman geneticsDOAJ
  5. P038 Sequential bilateral central retinal artery occlusion despite high-dose glucocorticoid therapy in biopsy-proven giant cell arteritis
    Rheumatology advances in practicePeer-reviewedCC BYFull textGeneral medicineEurope PMC
BibTeX
@article{ambiya2026combined,
  title = {{Combined central retinal and posterior ciliary artery occlusion in a young female with primary myelofibrosis and Sweet’s syndrome: A case report}},
  author = {Vikas Ambiya and Srishti Khullar and Gaurav Kapoor},
  journal = {Taiwan Journal of Ophthalmology},
  year = {2026},
  month = jul,
  doi = {10.4103/tjo.tjo-d-25-00176},
  url = {https://doi.org/10.4103/tjo.tjo-d-25-00176},
  note = {CC BY-NC-ND},
}
RIS
TY  - JOUR
TI  - Combined central retinal and posterior ciliary artery occlusion in a young female with primary myelofibrosis and Sweet’s syndrome: A case report
AU  - Vikas Ambiya
AU  - Srishti Khullar
AU  - Gaurav Kapoor
PY  - 2026
DA  - 2026/07/01
JO  - Taiwan Journal of Ophthalmology
DO  - 10.4103/tjo.tjo-d-25-00176
UR  - https://doi.org/10.4103/tjo.tjo-d-25-00176
AB  - Primary myelofibrosis (PMF) is a rare myeloproliferative neoplasm that typically affects older adults but may present aggressively in younger patients. Thromboembolic complications are well recognized, though arterial occlusions are uncommon in this age group. Ocular ischemia associated with systemic inflammatory conditions such as Sweet’s syndrome is exceedingly rare. A 22-year-old female with PMF, diagnosed 18 months earlier and managed initially with ruxolitinib, presented with sudden, complete loss of vision in her left eye. She also had a history of Sweet’s syndrome managed with oral corticosteroids and had received multiple blood transfusions. Ophthalmic evaluation revealed no light perception in the left eye, a pale retina with attenuated vessels, and a cherry-red spot. Optical coherence tomography (OCT) showed hyperreflectivity of the inner retinal layers, and OCT angiography demonstrated markedly reduced perfusion in all vascular plexuses. Carotid Doppler, echocardiography, and ECG excluded embolic sources. Despite ocular massage, anterior chamber paracentesis, acetazolamide, and anticoagulation with apixaban, vision did not recover. One week later, she developed anterior uveitis, keratic precipitates, and elevated intraocular pressure. Fundus showed Amalric’s sign of choroidal infarction and Elschnig spots, confirmed on fluorescein angiography. Inflammation responded to topical and systemic corticosteroids, with normalization of intraocular pressure. This is the first documented case of combined central retinal artery occlusion and posterior ciliary artery occlusion with anterior uveitis in a young PMF patient with Sweet’s syndrome. The case underscores the multifactorial contribution of hypercoagulability, systemic inflammation, and transfusion-related factors in ocular ischemia.
SN  - 2211-5056
SN  - 2211-5072
ER  -